These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16951553)

  • 1. Monoclonal antibody to CD9 inhibits platelet-induced human endothelial cell proliferation.
    Ko EM; Lee IY; Cheon IS; Kim J; Choi JS; Hwang JY; Cho JS; Lee DH; Kang D; Kim SH; Choe J
    Mol Cells; 2006 Aug; 22(1):70-7. PubMed ID: 16951553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor.
    Worthington RE; Carroll RC; Boucheix C
    Br J Haematol; 1990 Feb; 74(2):216-22. PubMed ID: 2317457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet antigens CD9, CD42 and integrin alpha IIb beta IIIa can be topographically associated and transduce functionally similar signals.
    Slupsky JR; Kamiguti AS; Rhodes NP; Cawley JC; Shaw AR; Zuzel M
    Eur J Biochem; 1997 Feb; 244(1):168-75. PubMed ID: 9063461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the dual effects on platelets of a monoclonal antibody to CD9, and on the properties of platelet CD9.
    Inngjerdingen M; Waterhouse K; Solum NO
    Thromb Res; 1999 Sep; 95(5):215-27. PubMed ID: 10515286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the signal-initiating membrane protein CD9 is associated with small GTP-binding proteins.
    Seehafer JG; Shaw AR
    Biochem Biophys Res Commun; 1991 Aug; 179(1):401-6. PubMed ID: 1909120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD9 monoclonal antibody activates p72syk in human platelets.
    Ozaki Y; Satoh K; Kuroda K; Qi R; Yatomi Y; Yanagi S; Sada K; Yamamura H; Yanabu M; Nomura S
    J Biol Chem; 1995 Jun; 270(25):15119-24. PubMed ID: 7541034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD9 participates in endothelial cell migration during in vitro wound repair.
    Klein-Soyer C; Azorsa DO; Cazenave JP; Lanza F
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):360-9. PubMed ID: 10669631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of CD9, CD32 and p67 signalling: use of degranulated platelets indicates direct involvement of CD9 and p67 in integrin activation.
    Slupsky JR; Cawley JC; Kaplan C; Zuzel M
    Br J Haematol; 1997 Feb; 96(2):275-86. PubMed ID: 9029013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD9 clustering and formation of microvilli zippers between contacting cells regulates virus-induced cell fusion.
    Singethan K; Müller N; Schubert S; Lüttge D; Krementsov DN; Khurana SR; Krohne G; Schneider-Schaulies S; Thali M; Schneider-Schaulies J
    Traffic; 2008 Jun; 9(6):924-35. PubMed ID: 18363777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticle generation during in vitro platelet activation by anti-CD9 murine monoclonal antibodies.
    Nomura S; Nagata H; Suzuki M; Kondo K; Ohga S; Kawakatsu T; Kido H; Fukuori T; Yamaguchi K; Iwata K
    Thromb Res; 1991 Jun; 62(5):429-39. PubMed ID: 1896962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraspanin CD9 is required for microparticle release from coated-platelets.
    Dale GL; Remenyi G; Friese P
    Platelets; 2009 Sep; 20(6):361-6. PubMed ID: 19658001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies.
    Jennings LK; Fox CF; Kouns WC; McKay CP; Ballou LR; Schultz HE
    J Biol Chem; 1990 Mar; 265(7):3815-22. PubMed ID: 2303480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activation of human platelets mediated by two monoclonal antibodies raised against CD9.
    Peng L; Li JZ; Wu HZ; Wang MJ
    Thromb Res; 1997 Jul; 87(1):65-73. PubMed ID: 9253801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of platelet fibrinogen receptors by a monoclonal antibody to CD9 antigen.
    Hato T; Ikeda K; Yasukawa M; Watanabe A; Kobayashi Y
    Blood; 1988 Jul; 72(1):224-9. PubMed ID: 2455569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-localization of CD9 and GPIIb-IIIa (alpha IIb beta 3 integrin) on activated platelet pseudopods and alpha-granule membranes.
    Brisson C; Azorsa DO; Jennings LK; Moog S; Cazenave JP; Lanza F
    Histochem J; 1997 Feb; 29(2):153-65. PubMed ID: 9147072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD9 monoclonal antibody-stimulated invasion of endometrial cancer cell lines in vitro: possible inhibitory effect of CD9 in endometrial cancer invasion.
    Park KR; Inoue T; Ueda M; Hirano T; Higuchi T; Konishi I; Fujiwara H; Fujii S
    Mol Hum Reprod; 2000 Aug; 6(8):719-25. PubMed ID: 10908282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive C1q-complement initiated lysis of human platelets by IgG subclass murine monoclonal antibodies to the CD9 antigen.
    Carroll RC; Rubinstein E; Worthington RE; Boucheix C
    Thromb Res; 1990 Sep; 59(5):831-9. PubMed ID: 2146768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets.
    Israels SJ; McMillan-Ward EM; Easton J; Robertson C; McNicol A
    Thromb Haemost; 2001 Jan; 85(1):134-41. PubMed ID: 11204565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet alpha-granule and plasma membrane share two new components: CD9 and PECAM-1.
    Cramer EM; Berger G; Berndt MC
    Blood; 1994 Sep; 84(6):1722-30. PubMed ID: 8080982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells.
    Longo N; Yáñez-Mó M; Mittelbrunn M; de la Rosa G; Muñoz ML; Sánchez-Madrid F; Sánchez-Mateos P
    Blood; 2001 Dec; 98(13):3717-26. PubMed ID: 11739177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.